Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis of the Lumbar Spine [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating X0002 Spray for osteoarthritis of the lumbar spine has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Lumbar Spine
• Pain

Drugs mentioned

• X0002 Spray

Snippet

Sponsor: Techfields Pharma Co. Ltd | Conditions: Osteoarthritis of the Lumbar Spine, Pain, Back | Phase 3 | Status: WITHDRAWN